PER
Click for more information
1.41% 7.0¢ percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-171

  1. Akki
    35,730 Posts.
    lightbulb Created with Sketch. 554
    clock Created with Sketch.
    04/08/24
    21:19
    Post #: 75065397
    Pfizer was already behind Sarepta in the GT battle but the expanded label really nailed it down.
    PER Price at posting: 7.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MND Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
right-arrow Created with Sketch.
POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
TG1 TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
right-arrow Created with Sketch.
MAG Magmatic defines 6km copper trend with grades of up to 6.5% at NSW prospect
right-arrow Created with Sketch.
STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
LML Lincoln repositions Kookaburra for low-cost graphite delivery
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
-0.001(1.41%) 		Mkt cap ! $63.10M
Open High Low Value Volume
7.1¢ 7.1¢ 6.9¢ $34.01K 486.5K

Buyers (Bids)

No. Vol. Price($)
2 132919 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 78000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.